Maria Chiara Monaco Selected Research

Stroke (Strokes)

5/2014

JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Chiara Monaco Research Topics

Disease

4	Infections 01/2022 - 12/2013
4	Multiple Sclerosis 01/2022 - 09/2010
3	Progressive Multifocal Leukoencephalopathy 01/2021 - 09/2010
2	Inflammation (Inflammations) 01/2022 - 08/2018
2	Brain Diseases (Brain Disorder) 12/2019 - 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	hypohidrotic Ectodermal dysplasia with immune deficiency 01/2016
1	Anhidrotic Ectodermal Dysplasia 1 01/2016
1	Stroke (Strokes) 05/2014
1	Immune Reconstitution Inflammatory Syndrome 09/2010

Drug/Important Bio-Agent (IBA)

3	Natalizumab (Tysabri)FDA Link 01/2022 - 09/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2010
1	nitazoxanide (NTZ)FDA Link 01/2022
1	Viral AntigensIBA 01/2022
1	AntigensIBA 01/2021
1	ruxolitinibIBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 08/2018
1	InflammasomesIBA 01/2018
1	I-kappa B KinaseIBA 01/2016
1	ImmunosorbentsIBA 05/2014
1	AntibodiesIBA 05/2014
1	EnzymesIBA 05/2014

Therapy/Procedure

3	Therapeutics 12/2019 - 12/2013
1	Immunotherapy 01/2021
1	Plasma Exchange 09/2010